Your browser doesn't support javascript.
loading
Extrachromosomal circular DNA orchestrates genome heterogeneity in urothelial bladder carcinoma.
Lv, Wei; Pan, Xiaoguang; Han, Peng; Wu, Shuang; Zeng, Yuchen; Wang, Qingqing; Guo, Lidong; Xu, Mengyang; Qi, Yanwei; Deng, Li; Xu, Zhe; Li, Conghui; Yu, Tianxi; Cui, Xin; Teng, Huajing; Xiang, Chongjun; Tan, Haotian; Li, Yue; Liang, Ning; Tao, Huiying; Gao, Qingqing; Yu, Guohua; Mi, Jia; Xu, Fuyi; Gong, Benjiao; Shi, Lei; Wang, Tao; Yang, Huanming; Dong, Wei; Bolund, Lars; Lin, Lin; Wang, Wenting; Li, Hanbo; Huang, Jinrong; Lin, Chunhua; Luo, Yonglun.
Afiliação
  • Lv W; Lars Bolund Institute of Regenerative Medicine, HIM-BGI Omics Center, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
  • Pan X; College of Life Sciences, University of Chinese Academy of Science, Beijing 100049, China.
  • Han P; Lars Bolund Institute of Regenerative Medicine, Qingdao-Europe Advanced Institute for Life Sciences, BGI-Research, Qingdao 266555, China.
  • Wu S; BGI-Research, Shenzhen, 518083, China.
  • Zeng Y; Lars Bolund Institute of Regenerative Medicine, Qingdao-Europe Advanced Institute for Life Sciences, BGI-Research, Qingdao 266555, China.
  • Wang Q; BGI-Research, Shenzhen, 518083, China.
  • Guo L; Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, 264000, China.
  • Xu M; Lars Bolund Institute of Regenerative Medicine, HIM-BGI Omics Center, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
  • Qi Y; College of Life Sciences, University of Chinese Academy of Science, Beijing 100049, China.
  • Deng L; College of Life Sciences, University of Chinese Academy of Science, Beijing 100049, China.
  • Xu Z; BGI-Research, Shenzhen, 518083, China.
  • Li C; BGI-Research, Shenzhen, 518083, China.
  • Yu T; BGI-Research, Shenzhen, 518083, China.
  • Cui X; BGI-Research, Shenzhen, 518083, China.
  • Teng H; College of Life Sciences, University of Chinese Academy of Science, Beijing 100049, China.
  • Xiang C; Lars Bolund Institute of Regenerative Medicine, HIM-BGI Omics Center, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
  • Tan H; Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, 264000, China.
  • Li Y; School of Clinical Medicine, Weifang Medical University, Weifang, 261042, China.
  • Liang N; Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, 264000, China.
  • Tao H; School of Clinical Medicine, Weifang Medical University, Weifang, 261042, China.
  • Gao Q; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
  • Yu G; Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, 264000, China.
  • Mi J; The 2nd Medical College of Binzhou Medical University, Yantai, Shandong, 264003, China.
  • Xu F; Department of Urology, China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100029, China.
  • Gong B; Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, 264000, China.
  • Shi L; The 2nd Medical College of Binzhou Medical University, Yantai, Shandong, 264003, China.
  • Wang T; Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, 264000, China.
  • Yang H; School of Clinical Medicine, Weifang Medical University, Weifang, 261042, China.
  • Dong W; Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, 264000, China.
  • Bolund L; The 2nd Medical College of Binzhou Medical University, Yantai, Shandong, 264003, China.
  • Lin L; Lars Bolund Institute of Regenerative Medicine, HIM-BGI Omics Center, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
  • Wang W; College of Life Sciences, University of Chinese Academy of Science, Beijing 100049, China.
  • Li H; Department of Pathology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, 264000, China.
  • Huang J; Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, School of Pharmacy, Binzhou Medical University, Yantai, Shandong, China.
  • Lin C; Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, School of Pharmacy, Binzhou Medical University, Yantai, Shandong, China.
  • Luo Y; Department of Central Laboratory, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, China.
Theranostics ; 14(13): 5102-5122, 2024.
Article em En | MEDLINE | ID: mdl-39267784
ABSTRACT
Rationale Extrachromosomal circular DNA is a hallmark of cancer, but its role in shaping the genome heterogeneity of urothelial bladder carcinoma (UBC) remains poorly understood. Here, we comprehensively analyzed the features of extrachromosomal circular DNA in 80 UBC patients.

Methods:

We performed whole-genome/exome sequencing (WGS/WES), Circle-Seq, single-molecule real-time (SMRT) long-read sequencing of circular DNA, and RNA sequencing (RNA-Seq) on 80 pairs of tumor and AT samples. We used our newly developed circular DNA analysis software, Circle-Map++ to detect small extrachromosomal circular DNA from Circle-Seq data.

Results:

We observed a high load and significant heterogeneity of extrachromosomal circular DNAs in UBC, including numerous single-locus and complex chimeric circular DNAs originating from different chromosomes. This includes highly chimeric circular DNAs carrying seven oncogenes and circles from nine chromosomes. We also found that large tumor-specific extrachromosomal circular DNAs could influence genome-wide gene expression, and are detectable in time-matched urinary sediments. Additionally, we found that the extrachromosomal circular DNA correlates with hypermutation, copy number variation, oncogene amplification, and clinical outcome.

Conclusions:

Overall, our study provides a comprehensive extrachromosomal circular DNA map of UBC, along with valuable data resources and bioinformatics tools for future cancer and extrachromosomal circular DNA research.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / DNA Circular / Variações do Número de Cópias de DNA Limite: Aged / Female / Humans / Male Idioma: En Revista: Theranostics Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / DNA Circular / Variações do Número de Cópias de DNA Limite: Aged / Female / Humans / Male Idioma: En Revista: Theranostics Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China